Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Gu, J ^a   Lu, Y ^a,b   Li, F ^c   Qiao, L ^a   Wang, Q ^a   Li, N ^a   Borgia, J A ^b   Deng, Y ^b   Lei, G ^d   Zheng, Q ^a,b  

^a JIANGSU UNIVERSITY   (China)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 12; CIS ACTING ELEMENT; COL10A1; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; COL10A1 PROTEIN, MOUSE; COLLAGEN TYPE 10; PROTEIN BINDING; PTGS2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARTILAGE CELL; CELL DIFFERENTIATION; COMPUTER MODEL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HYPERTROPHY; IMMORTALIZED CELL LINE; MASS SPECTROMETRY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SEQUENCE ANALYSIS; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; BIOLOGY; CHEMISTRY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TWO HYBRID SYSTEM;

MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CHONDROCYTES; COLLAGEN TYPE X; COMPUTATIONAL BIOLOGY; CYCLOOXYGENASE 2; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTROPHY; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84928017050     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.444     Document Type: Article

References (75)

1. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008; 40: 46-62.
2. Lu Y, Qiao L, Lei G, Mira RR, Gu J, Zheng Q. Col10a1 gene expression and chondrocyte hypertrophy during skeletal development and disease. Front Biol 2014; 9: 195-204.
3. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423: 332-336.
4. Shen G. The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage. Orthod Craniofac Res 2005; 8: 11-17.
5. Grskovic I, Kutsch A, Frie C, Groma G, Stermann J, Schlötzer-Schrehardt U et al. Depletion of annexin A5, annexin A6, and collagen X causes no gross changes in matrix vesiclemediated mineralization, but lack of collagen X affects hematopoiesis and the Th1/Th2 response. J Bone Miner Res 2012; 27: 2399-2412.
6. Warman ML, Abbott M, Apte SS, Hefferon T, McIntosh I, Cohn DH et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet 1993; 5: 79-82.
7. von der Mark K, Frischholz S, Aigner T, Beier F, Belke J, Erdmann S et al. Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop Scand Suppl 1995; 266: 125-129.
8. Girkontaite I, Frischholz S, Lammi P, Wagner K, Swoboda B, Aigner T et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996; 15: 231-238.
9. Ikegawa S, Nishimura G, Nagai T, Hasegawa T, Ohashi H, Nakamura Y. Mutation of the type X collagen gene (COL10A1) causes spondylometaphyseal dysplasia. Am J Hum Genet 1998; 63: 1659-1662.
10. Drissi H, Zuscik M, Rosier R, O'Keefe R. Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis. Mol Aspects Med. 2005; 26: 169-179.
11. Zheng Q, Sebald E, Zhou G, Chen Y, Wilcox W, Lee B et al. Dysregulation of chondrogenesis in human cleidocranial dysplasia. Am J Hum Genet 2005; 77: 305-312.
12. Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007; 9: R75.
13. Saito T, Fukai A, Mabuchi A, Ikeda T, Yano F, Ohba S et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010; 16: 678-686.
14. Lamas JR, Rodríguez-Rodríguez L, Vigo AG, Alvarez-Lafuente R, López-Romero P, Marco F et al. Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritis. Ann Rheum Dis 2010; 69: 1880-1885.
15. Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 2010; 26: 216-227.
16. Wallis GA, Rash B, Sweetman WA, Thomas JT, Super M, Evans G et al. Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid. Am J Hum Genet 1994; 54: 169-178.
17. McIntosh I, Abbott MH, Francomano CA. Concentration of mutations causing Schmid metaphyseal chondrodysplasia in the C-terminal noncollagenous domain of type X collagen. Hum Mutat 1995; 5: 121-125.
18. Kwan KM, Pang MK, Zhou S, Cowan SK, Kong RY, Pfordte T et al. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol 1997; 136: 459-471.
19. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 1997; 16: 307-310.
20. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-771.
21. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-764.
22. Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D et al. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet 1999; 8: 2311-2316.
23. Kim IS, Otto F, Zabel B, Mundlos S. Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 1999; 80: 159-170.
24. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 1999; 214: 279-290.
25. Mwale F, Girard-Lauriault PL, Wang HT, Lerouge S, Antoniou J, Wertheimer MR. Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings. Tissue Eng 2006; 12: 2639-2647.
26. Petit A, Wang HT, Girard-Lauriault PL, Wertheimer MR, Antoniou J, Mwale F. Novel insights into the mechanism of decreased expression of type X collagen in human mesenchymal stem cells from patients with osteoarthritis cultured on nitrogen-rich plasma polymers: implication of cyclooxygenase-1. J Biomed Mater Res A 2010; 94: 744-750.
27. Riemer S, Gebhard S, Beier F, Poschl E, Von Der Mark K. Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: Localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer. J Cell Biochem 2002; 86: 688-699.
28. Magee C, Nurminskaya M, Faverman L, Galera P, Linsenmayer TF. SP3/SP1 transcription activity regulates specific expression of collagen typeX in hypertrophic chondrocytes. J Biol Chem 2005; 280: 25331-25338.
29. Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N et al. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 2005; 280: 38544-38555.
30. Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, Qi X et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 2007; 12: 377-389.
31. Dy P, Wang W, Bhattaram P, Wang Q, Wang L, Ballock RT et al. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev Cell 2012; 22: 597-609.
32. Maruyama T, Miyamoto Y, Yamamoto G, Yamada A, Yoshimura K, Suzawa T et al. Downregulation of carbonic anhydrase IX promotes Col10a1 expression in chondrocytes. PLoS One 2013; 8: e56984.
33. Adams SL, Pallante K M, Niu Z, Cohen AJ, Lu J, LeBoy PS. Stimulation of type-X collagen gene transcription by retinoids occurs in part through the BMP signaling pathway. J Bone Joint Surg Am 2003; 85-A: 29-33.
34. Dong Y, Drissi H, Chen M, Chen D, Zuscik MJ, Schwarz EM et al. Wnt-mediated regulation of chondrocyte maturation: Modulation by TGF-beta. J Cell Biochem 2005; 95: 1057-1068.
35. Schipani E, Provot S. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. Birth Defects Res C Embryo Today 2003; 69: 352-362.
36. Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 2003; 162: 833-842.
37. Zheng Q, Keller B, Zhou G, Napierala D, Chen Y, Zabel B et al. Localization of the cisenhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. J Bone Miner Res 2009; 24: 1022-1032.
38. Li F, Lu Y, Ding M, Napierala D, Abbassi S, Chen Y et al. Runx2 contributes to murine Col10a1 gene regulation through direct interaction with its cis-enhancer. J Bone Miner Res 2011; 26: 2899-2910.
39. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Database on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367.
40. Vares G, Uehara Y, Ono T, Nakajima T,Wang B, Taki K et al. Transcription factor-recognition sequences potentially involved in modulation of gene expression after exposure to low-doserate γ-rays in the mouse liver. J Radiat Res 2011; 52: 249-256.
41. Messeguer X, Escudero R, Farré D, Núñez O, Martínez J, Albà MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002; 18: 333-334.
42. Farré D, Roset R, Huerta M, Adsuara JE, Roselló L, Albà MM et al. Identification of patterns in biological sequences at the ALGGEN server: PROMOand MALGEN. Nucleic Acids Res 2003; 31: 3651-3653.
43. Thomas-Chollier M, Hufton A, Heinig M, O'Keeffe S, Masri NE, Roider HG et al. Transcription factor binding predictions using TRAP for the analysis of ChIP- seq data and regulatory SNPs. Nat Protoc 2011; 6: 1860-1869.
44. Kel AE, Gössling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003; 31: 3576-3579.
45. Miller AK, Print CG, Nielsen PM, Crampin EJ. Hox genes regulate the onset of Tbx5 expression in the forelimb. PLoS One 2010; 5: e13897.
46. Lefebvre V, Garofalo S, de Crombrugghe B. Type X collagen gene expression in mouse chondrocytes immortalized by a temperaturesensitive simian virus 40 large tumor antigen. J Cell Biol 1995; 128: 239-245.
47. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
48. Beier F, Vornehm S, Pöschl E, von der Mark K, Lammi MJ. Localization of silencer and enhancer elements in the human type X collagen gene. J Cell Biochem 1997; 66: 210-218.
49. Long F, Sonenshein GE, Linsenmayer TF. Multiple transcriptional elements in the avian type X collagen gene. Identification of Sp1 family proteins as regulators for high level expression in hypertrophic chondrocytes. J Biol Chem 1998; 273: 6542-6549.
50. Volk SW, Luvalle P, Leask T, Leboy PS. A BMP responsive transcriptional region in the chicken type X collagen gene. J Bone Miner Res 1998; 13: 1521-1529.
51. Gebhard S, Poschl E, Riemer S, Bauer E, Hattori T, Eberspaecher H et al. A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue specific expression in hypertrophic cartilage in vitro and in vivo. Matrix Biol 2004; 23: 309-322.
52. Sandelin A. Prediction of regulatory elements. Methods Mol Biol 2008; 453: 233-244.
53. Wingender E, Dietze P, Karas H, Knüppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res 1996; 24: 238-241.
54. Wu S, Flint JK, Rezvani G, De Luca F. Nuclear factor-kappaB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem 2007; 282: 33698-33706.
55. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 2001; 29: 281-283.
56. Moritani NH, Kubota S, Eguchi T, Fukunaga T, Yamashiro T, Takano-Yamamoto T et al. Interaction of AP-1 and the ctgf gene: a possible driver of chondrocyte hypertrophy in growth cartilage. J Bone Miner Metab 2003; 21: 205-210.
57. Lengner CJ, Lepper C, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Primary mouse embryonic fibroblasts: a model of mesenchymal cartilage formation. J Cell Physiol 2004; 200: 327-333.
58. Agueda L, Bustamante M, Jurado S, Garcia-Giralt N, Ciria M, Saló G et al. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women. J Bone Miner Res 2008; 23: 1954-1963.
59. Minguillon C, Nishimoto S, Wood S, Vendrell E, Gibson-Brown JJ, Logan MP. A Bayesian search for transcriptional motifs. Development 2012; 139: 3180-3188.
60. Welting TJ, Caron MM, Emans PJ, Janssen MP, Sanen K, Coolsen MM et al. Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification. Eur Cell Mater 2011; 22: 420-436.
61. Mikic B, Ferreira MP, Battaglia TC, Hunziker EB. Accelerated hypertrophic chondrocyte kinetics in GDF-7 deficient murine tibial growth plates. J Orthop Res 2008; 26: 986-990.
62. LeClair EE, Bonfiglio L, Tuan RS. Expression of the paired-box genes Pax-1 and Pax-9 in limb skeleton development. Dev Dyn 1999; 214: 101-115.
63. Takimoto A, Mohri H, Kokubu C, Hiraki Y, Shukunami C. Pax1 acts as a negative regulator of\ chondrocyte maturation. Exp Cell Res 2013; 319: 3128-3139.
64. Weston AD, Underhill TM. Analysis of Nedd4 expression during skeletal development in the mouse limb. Mech Dev 2000; 94: 247-250.
65. Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res 1997; 12: 1174-1188.
66. Gu J, Lu Y, Qiao L, Ran D, Li N, Cao H, Gao Y, Zheng Q. Mouse p63 variants and chondrogenesis. Int J Clin Exp Pathol 2013; 6: 2872-2879 eCollection 2013.
67. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I,Wong N et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 2002; 20: 1164-1169.
68. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109: 1405-1415.
69. Drissi H, Li X, Sheu T, Zuscik MJ, Schwarz EM, Puzas JE et al. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem 2003; 90: 1287-1298.
70. Simões B, Conceição N, Viegas CS, Pinto JP, Gavaia PJ, Hurst LD et al. Identification of a promoter element within the zebrafish colXalpha1 gene responsive to runx2 isoforms Osf2/Cbfa1 and til-1 but not to pebp2alphaA2. Calcif Tissue Int 2006; 79: 230-244.
71. Higashikawa A, Saito T, Ikeda T, Kamekura S, Kawamura N, Kan A et al. Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis Rheum 2009; 60: 166-178.
72. Susperregui AR, Gamell C, Rodríguez-Carballo E, Ortuño MJ, Bartrons R, Rosa JL et al. Noncanonical BMP signaling regulates cyclooxygenase-2 transcription. Mol Endocrinol 2011; 25: 1006-1017.
73. Leung VY, Gao B, Leung KK, Melhado IG, Wynn SL, Au TY, Dung NW, Lau JY, Mak AC, Chan D, Cheah KS. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet 2011; 7: e1002356.
74. Zanotti S, Canalis E. Notch suppresses nuclear factor of activated T cells (NFAT) transactivation and Nfatc1 expression in chondrocytes. Endocrinology 2013; 154: 762-772.
75. Wang J, Gardner BM, Lu Q, Rodova M, Woodbury BG, Yost JG et al. Transcription factor Nfat1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes. J Pathol 2009; 219: 163-172.